Progress in Japanese herbal medicine in treatment of chronic kidney disease

Zhongguo Zhongyao Zazhi

Volumn 33, Issue 11, 2008, Pages 1348-1352

  Wang, Jing ^a   Wan, Yi Gang ^b   Sun, Wei ^a   Zhang, Hui Lan ^a   Chen, Ping ^a   Yao, Jian ^c  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Chronic kidney disease (CKD); Onpi to; Sairei to

Indexed keywords

PLANT EXTRACT;

ANIMAL; CHRONIC DISEASE; HERBAL MEDICINE; HUMAN; JAPAN; KIDNEY DISEASE; METABOLISM; PATHOLOGY; PHYTOTHERAPY; REVIEW;

ANIMALS; CHRONIC DISEASE; HERBAL MEDICINE; HUMANS; JAPAN; KIDNEY DISEASES; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 50249168135     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Levey A S, Eckardt K U, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO) [J]. Kidney Int, 2005,67(6):2089.
2. Chinese source
3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney diseases: evaluation, classification, and stratification[J]. Am J Kidney Dis, 2002,39(2 suppl 1):S1-S266.
4. Kunitoshi I. CKD surveillance in japan[J]. Jpn J Nephrol, 2007,49(3):206.
5. Chinese source
6. Niriaki-Yorioka. eds. Renal diseases-state of arts [M]. 2003:186.
7. Shimizu F, Kawachi H, Orikasa M. Role of mesangial cell damage in progressive renal disease[J]. Kidney Blood Press Res, 1999,22(1-2):5.
8. Kawachi H, Takashima N, Orikasa M, et al. Effect of traditional Chinese medicine (sairei-to) on monoclonal antibody-induced proteinuria in rats[J]. Pathol Int, 1994,44(5):339.
9. Li P, Kawachi H, Morioka T, et al. The prevention of glomerulosclerosis in rats using traditional Chinese medicine, Sairei-to [J]. Nephrology, 2000,5:83.
10. Awazu M, Fujita H, Omori S, et al. The herbal medicine Sairei-to inhibits proliferation of rat mesangial cells[J]. Nephron, 2002,92(3):652.
11. Yohei I, Katsue K, Tamaki K, et al. The role of lymphocytes in the experimental progressive glomerulonephritis[J]. Kidney Int, 2004,66:1036.
12. Li P, Gong Y, Zu N, et al. Therapeutic mechanism of saikosaponin-d in anti-Thy1 mAb 1-22-3-induced rat model of glomerulonephritis[J]. Nephron Exp Nephrol, 2005,101:e111.
13. Ning L, Takahiko O, Gisho H. Suppressive effects of sairei-to on mesangial proliferation in a rat model of glomerulonephritis[J]. Clin Exp Nephrol, 2004,8:216.
14. Ito Y, Goldschmeding R, Bende RJ, et al. Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis[J] . J Am Soc Nephrol, 2001,12:472.
15. Takahiko O, Ning L, Toshiaki M, et al. Suppressive mechanisms of sairei-to on mesangial matrix expansion in rat mesangioproliferative glomerulonephritis[J]. Nephron Exp Nephrol, 2005,100:e132.
16. Saegusa Y, Sugiyama A, Takahara A, et al. Relationship between phosphodiesterase inhibition induced by several kampo medicines and smooth muscle relaxation of gastrointestinal tract tissues of rats[J]. J Pharmacol Sci, 2003,93:62.
17. Chatziantoniou C, Dussaule J C. Endothelin and renal vascular fibrosis of mice and men[J]. Curr Opin Nephrol Hyperten, 2000,9:31.
18. Tomohisa H, Naoki F, Akiko K, et al. Saireito may inhibit the synthesis of endothelin-1 in nephritic glomeruli[J]. Jpn J Nephrol, 1997,39(2):121.
19. Nakamura K, Oka M, Shirai M, et al. Source of reactive oxygen species in anti-thy-1 nephritis[J]. Ren Fail, 1998,20:399.
20. Blasi E R, Rocha R, Rudolph AE, et al. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats[J]. Kidney Int, 2002,63:1791.
21. Tomohisa H, Hirofumi M, Hiroki N, et al. Effects of saireito, a Japanese herbal medicine, on edema via antagonistic actione against aldosterone in anti-GBM nephritic rats[J]. Clin Exp Nephrol, 2006,10:13.
22. Tadamichi M, Takako Y, Hikokichi O, et al. Clinical evaluation of Kampo medication, mainly with Wen-pi-tang, on the progression of chronic renal failure[J]. Jpn J Nephrol, 1999,41(8):769.
23. Chinese source
24. Takako Y, Akiko S, Takako N, et al. Attenuating effects of Wen-pi-tang treatment in rats with diabetic nephropathy[J]. Am J Chin Med, 2006,34(2):307.
25. Bottinger E P, Bitzer M. TGF-beta signaling in renal disease [J]. J Am Soc Nephrol, 2002,13:260.
26. Lee S I, Kim H J, Baek M C, et al. Wen-pi-tang-Hab-Wu-ling-san, an oriental herbal prescription, attenuates epithelial-mesenchymal transdifferentiation stimulated by TGF-β1 in kidney cell[J]. Phytother Res, 2007,21:548.
27. Chinese source
28. Chinese source
29. Chinese source
30. Chinese source